retatrutide weight loss results clinical trial Results:Trial Data and FDA Status retatrutide clinical trial results weight

Safety and efficacy of erenumab for preventive treatment of chronic migraine: A randomised, double-blind, placebo-controlled phase 2 trial

Sometimes this fails, which can lead to infection

Eli Lilly's Phase 3 trial program (TRIUMPH and TRANSCEND-T2D) has reported results from three registration trials including the pivotal obesity trial that anchors the weight-management filing

However, emerging data and mechanistic plausibility suggest that certain populations may be at higher risk of suboptimal intake or depletion, particularly with prolonged therapy, rapid weight loss, restricted dietary variety or pre-existing marginal nutrient status

We conducted our analysis using the TriNetX database network, which includes a large and demographically diverse cohort of 41,646 patients

doi: 10.1080/17425255.2020.1767067 [DOI] [PubMed] [Google Scholar] 30